IMMUNOHISTOCHEMISTRY - MARKERS FOR SKIN CARCINOMAS AND MELANOMAS - ANVISA Registration 10287411082
Access comprehensive regulatory information for IMMUNOHISTOCHEMISTRY - MARKERS FOR SKIN CARCINOMAS AND MELANOMAS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10287411082 and manufactured by manufacturer not specified. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until Feb 02, 2035.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 4 companies making the same product including VENTANA MEDICAL SYSTEM, INC, LEICA BIOSYSTEMS NEWCASTLE LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Related Devices (2)
Registration Details
10287411082
25351686537201476
30280358000186
Company Information
Dates and Status
Feb 02, 2015
02/02/2035
09/18/2025 19:00:01
IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS DE PELE E MELANOMAS
Anti-PRAME (EPR20330) Rabbit Monoclonal Primary Antibody
VENTANA MEDICAL SYSTEM, INC
10287411678
Oct 23, 2023
IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS DE PELE E MELANOMAS
Anti-PRAME (EPR20330) Rabbit Monoclonal Primary Antibody
Not specified
10287411678
Oct 23, 2023
IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS DE PELE E MELANOMAS
Família Anticorpo para Carcinoma de Pele e Melanoma
LEICA BIOSYSTEMS NEWCASTLE LTD
10337990046
Nov 23, 2020
IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS DE PELE E MELANOMAS
Família Anticorpo para Carcinoma de Pele e Melanoma
Not specified
10337990046
Nov 23, 2020
IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS DE PELE E MELANOMAS
Melanoma Triple Coktail (HMB45+A103+T311)
Not specified
10287411453
Oct 21, 2019

